Vecata
Investments
17Portfolio Exits
1
Want to inform investors similar to Vecata about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Vecata Investments
17 Investments
Vecata has made 17 investments. Their latest investment was in Mirrx as part of their Series A on September 9, 2009.
Vecata Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
9/1/2009 | Series A | Mirrx | Yes | 1 | ||
7/23/2008 | Unattributed VC | Fluxome Sciences | $17.2M | Yes | 1 | |
3/31/2008 | Series F | Chempaq | $4M | No | 1 | |
4/30/2007 | Series E | |||||
3/13/2007 | Series A |
Date | 9/1/2009 | 7/23/2008 | 3/31/2008 | 4/30/2007 | 3/13/2007 |
|---|---|---|---|---|---|
Round | Series A | Unattributed VC | Series F | Series E | Series A |
Company | Mirrx | Fluxome Sciences | Chempaq | ||
Amount | $17.2M | $4M | |||
New? | Yes | Yes | No | ||
Co-Investors | |||||
Sources | 1 | 1 | 1 |
Vecata Portfolio Exits
1 Portfolio Exit
Vecata has 1 portfolio exit. Their latest portfolio exit was Fluxome Sciences on November 29, 2012.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
11/29/2012 | Asset Sale | 1 |
Date | 11/29/2012 |
|---|---|
Exit | Asset Sale |
Companies | |
Valuation | |
Acquirer | |
Sources | 1 |
Vecata Team
1 Team Member
Vecata has 1 team member, including current Chief Executive Officer, Hans-Henrik Eriksen.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.